Catalyst Wire Dossier Catalyst Wire Dossier

VELGRAFT

· Ayu, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VELGRAFT, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue [Phase 1]

See pricing